Incidence, risk factors and prevention of melanoma
- PMID: 9849401
- DOI: 10.1016/s0959-8049(98)00003-3
Incidence, risk factors and prevention of melanoma
Abstract
The incidence of cutaneous malignant melanoma steadily increased between 1940 and 1990 in both sexes. However, this increase appears to have peaked in females in Scotland. Excessive exposure to ultraviolet radiation among Caucasians is the main etiologic factor implicated in the incidence of melanoma. Mortality due to melanoma also increased between 1940 and 1990, but the rate of increase is less than that of the incidence of melanoma. This may be due to earlier diagnosis and treatment of melanoma as a result of public education campaigns. Independent risk factors for developing melanoma include the presence of benign melanocytic naevi (moles), the development of lentigines or freckles, three or more dysplastic naevi and a history of three or more severe sunburns that resulted in peeling or blistering. Approximately 2% of melanoma patients have a family history of the disease and research into potential melanoma susceptibility genes is ongoing. Primary prevention campaigns, initiated mainly in Australia, are aimed at encouraging sensible sun exposure. Secondary prevention campaigns are directed at preventing death from melanoma by encouraging early diagnosis and treatment. Additional prospective studies are needed to determine if the incidence of melanoma has peaked and whether the recent trends observed in females will also occur in males.
Similar articles
-
[Risk factors for the development of malignant melanoma and identification of risk groups in German-speaking regions].Hautarzt. 1995 May;46(5):309-14. doi: 10.1007/s001050050257. Hautarzt. 1995. PMID: 7607893 Review. German.
-
Ultraviolet light exposure, pigmentary traits and the development of melanocytic naevi and cutaneous melanoma. A case-control study of the German Central Malignant Melanoma Registry.Acta Derm Venereol. 1997 Sep;77(5):374-8. doi: 10.2340/0001555577374378. Acta Derm Venereol. 1997. PMID: 9298131
-
Recent developments in melanoma epidemiology, 1993.Melanoma Res. 1993 Jun;3(3):149-56. doi: 10.1097/00008390-199306000-00002. Melanoma Res. 1993. PMID: 8400852 Review.
-
Epidemiology on malignant melanoma in Europe.Acta Oncol. 1992;31(8):903-8. doi: 10.3109/02841869209089727. Acta Oncol. 1992. PMID: 1290637
-
Etiology, epidemiology, risk factors, and public health issues of melanoma.Curr Opin Oncol. 1993 Mar;5(2):358-63. doi: 10.1097/00001622-199303000-00015. Curr Opin Oncol. 1993. PMID: 8457619 Review.
Cited by
-
1,3-Bis(3,5-dichlorophenyl) urea compound 'COH-SR4' inhibits proliferation and activates apoptosis in melanoma.Biochem Pharmacol. 2012 Dec 1;84(11):1419-27. doi: 10.1016/j.bcp.2012.08.020. Epub 2012 Aug 28. Biochem Pharmacol. 2012. PMID: 22959823 Free PMC article.
-
The spectrum of melanocytic nevi and their clinical implications.J Dtsch Dermatol Ges. 2022 Apr;20(4):483-504. doi: 10.1111/ddg.14776. J Dtsch Dermatol Ges. 2022. PMID: 35446494 Free PMC article. Review.
-
Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations.J Mol Diagn. 2001 Nov;3(4):158-63. doi: 10.1016/S1525-1578(10)60667-8. J Mol Diagn. 2001. PMID: 11687599 Free PMC article.
-
Sunlight and Vitamin D: A global perspective for health.Dermatoendocrinol. 2013 Jan 1;5(1):51-108. doi: 10.4161/derm.24494. Dermatoendocrinol. 2013. PMID: 24494042 Free PMC article. Review.
-
Effects of tailored risk communications for skin cancer prevention and detection: the PennSCAPE randomized trial.Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):415-21. doi: 10.1158/1055-9965.EPI-14-0926. Epub 2014 Nov 28. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25432953 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical